- Home
- BOOT vs IRTC Comparison
BOOT vs IRTC Comparison
Compare BOOT & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOOT
- IRTC
- Stock Information
- Founded
- BOOT 1978
- IRTC 2006
- Country
- BOOT United States
- IRTC United States
- Employees
- BOOT N/A
- IRTC N/A
- Industry
- BOOT Clothing/Shoe/Accessory Stores
- IRTC Medical/Dental Instruments
- Sector
- BOOT Consumer Discretionary
- IRTC Health Care
- Exchange
- BOOT Nasdaq
- IRTC Nasdaq
- Market Cap
- BOOT 3.3B
- IRTC 3.1B
- IPO Year
- BOOT 2014
- IRTC 2016
- Fundamental
- Price
- BOOT $117.49
- IRTC $137.70
- Analyst Decision
- BOOT Strong Buy
- IRTC Strong Buy
- Analyst Count
- BOOT 13
- IRTC 10
- Target Price
- BOOT $169.62
- IRTC $129.90
- AVG Volume (30 Days)
- BOOT 894.5K
- IRTC 517.4K
- Earning Date
- BOOT 05-20-2025
- IRTC 05-01-2025
- Dividend Yield
- BOOT N/A
- IRTC N/A
- EPS Growth
- BOOT 4.37
- IRTC N/A
- EPS
- BOOT 5.60
- IRTC N/A
- Revenue
- BOOT $1,845,814,000.00
- IRTC $618,587,000.00
- Revenue This Year
- BOOT $17.22
- IRTC $17.46
- Revenue Next Year
- BOOT $14.18
- IRTC $16.93
- P/E Ratio
- BOOT $21.11
- IRTC N/A
- Revenue Growth
- BOOT 8.31
- IRTC 20.54
- 52 Week Low
- BOOT $86.17
- IRTC $55.92
- 52 Week High
- BOOT $176.64
- IRTC $128.52
- Technical
- Relative Strength Index (RSI)
- BOOT 63.91
- IRTC 81.68
- Support Level
- BOOT $108.32
- IRTC $103.16
- Resistance Level
- BOOT $120.28
- IRTC $140.73
- Average True Range (ATR)
- BOOT 4.75
- IRTC 4.73
- MACD
- BOOT 2.43
- IRTC 3.63
- Stochastic Oscillator
- BOOT 90.72
- IRTC 93.01
About BOOT Boot Barn Holdings Inc.
Boot Barn Holdings Inc operates specialty retail stores. The company sells western and work-related footwear, apparel, and accessories in the United States. It is a single operating segment, which includes net sales generated from its retail stores and e-commerce websites.
About IRTC iRhythm Technologies Inc.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.